Ray Stevens, CEO of Structure Therapeutics, joins 'Squawk on the Street' to discuss the company's weight loss pill, ...
Nvidia has a structured data enablement strategy. Nvidia provides libaries, software and hardware to index and search data ...
The database of 200 million protein-structure predictions now includes homodimers, adding new biological relevance.
Structure Therapeutics (GPCR) stock jumped 10% after its GLP-1 pill aleniglipron posted 16.3% weight loss, outperforming Lilly and Novo's oral candidates.
Structure Therapeutics’ aleniglipron Phase 2 shows ~16% placebo-adjusted weight loss; a best-in-class oral GLP-1 with strong ...
Nvidia will structure hundreds of zettabytes per year of unstructured data to make it the ground truth for AI. AI will ...
Structure Therapeutics’ oral obesity drug elicited a placebo-adjusted weight loss of 16.3% at 44 weeks in a Phase 2 trial.
Ethereum whale profit ratios indicate early uptrend conditions, with no signs of market overheating or peak distribution.
Capital One Software, the enterprise B2B software business of Capital One, today announced new innovations for Capital One ...
Structure Therapeutics stock jumped 5.4%, closing at $56.65 on Monday, when it touted 16% weight loss - about 39 pounds – ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results